about
Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPDTiotropium Bromide in Chronic Obstructive Pulmonary Disease and Bronchial AsthmaMetabolic Functions of the Lung, Disorders and Associated PathologiesMolecular insights into the dynamics of pharmacogenetically important N-terminal variants of the human β2-adrenergic receptorASM-024, a piperazinium compound, promotes the in vitro relaxation of β2-adrenoreceptor desensitized tracheasAcetylation of retinal histones in diabetes increases inflammatory proteins: effects of minocycline and manipulation of histone acetyltransferase (HAT) and histone deacetylase (HDAC)Transient receptor potential (TRP) channels in the airway: role in airway disease.Arachidonate-regulated Ca(2+) influx in human airway smooth muscleAdvances in targeting cyclic nucleotide phosphodiesterasesLong-acting β2-agonists increase fluticasone propionate-induced mitogen-activated protein kinase phosphatase 1 (MKP-1) in airway smooth muscle cells.Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes.A novel model of IgE-mediated passive pulmonary anaphylaxis in rats.Refractory asthma: mechanisms, targets, and therapy.Severe Asthma: The Evolution of Patient-directed ManagementApolipoprotein mimetic peptides: a new approach for the treatment of asthma.PARP inhibition by olaparib or gene knockout blocks asthma-like manifestation in mice by modulating CD4(+) T cell functionLong-Acting Beta Agonists Enhance Allergic Airway DiseaseRegulator of G-protein signaling 2 repression exacerbates airway hyper-responsiveness and remodeling in asthmaGlucocorticoids regulate arrestin gene expression and redirect the signaling profile of G protein-coupled receptorsDJ-1 regulates mast cell activation and IgE-mediated allergic responses.Airway smooth muscle in the pathophysiology and treatment of asthma.Structural insights and functional implications of inter-individual variability in β2-adrenergic receptorStratified approaches to the treatment of asthma.Bifunctional ligands allow deliberate extrinsic reprogramming of the glucocorticoid receptor.Glucocorticoids recruit Tgfbr3 and Smad1 to shift transforming growth factor-β signaling from the Tgfbr1/Smad2/3 axis to the Acvrl1/Smad1 axis in lung fibroblasts.Role of transcription factors in the pathogenesis of asthma and COPD.Metabolic considerations of drugs in the treatment of allergic diseases.Eosinophil apoptosis as a therapeutic target in allergic asthma.A-kinase anchoring proteins: cAMP compartmentalization in neurodegenerative and obstructive pulmonary diseases.Pharmacologic rationale, efficacy and safety of the fixed-dose co-formulation of indacaterol and glycopyrronium.Pharmacological basis and scientific rationale underlying the targeted use of inhaled corticosteroid/long-acting β2-adrenergic agonist combinations in chronic obstructive pulmonary disease treatment.Phamacology of fluticasone furoate and vilanterol trifenatate combination therapy for asthma.Effect of budesonide and azelastine on histamine signaling regulation in human nasal epithelial cells.Mechanisms and treatments for severe, steroid-resistant allergic airway disease and asthma.Glucocorticoid and TNF signaling converge at A20 (TNFAIP3) to repress airway smooth muscle cytokine expressionFluticasone furoate and vilanterol trifenatate combination therapy for the treatment of asthma.A high-throughput chemical screen identifies novel inhibitors and enhancers of anti-inflammatory functions of the glucocorticoid receptor.Thiazolidinediones inhibit airway smooth muscle release of the chemokine CXCL10: in vitro comparison with current asthma therapies.Cyclic Adenosine Monophosphate-Mediated Enhancement of Vascular Endothelial Growth Factor Released by Differentiated Human Monocytic Cells: The Role of Protein Kinase A.Purinergic Signaling in Mast Cell Degranulation and Asthma.
P2860
Q26778685-8E55D044-B13C-4977-B035-37E42A3DBD12Q26780553-8590AAB4-FEF1-443D-968B-FD896E3AB010Q28072037-34FFCD03-4B8A-4FEE-838E-1542D805C917Q28542663-9FC8157F-E39E-467A-8BF5-53075C9DCBADQ28544879-767821F8-3E00-45FC-A8BF-66699DDC886DQ28579534-63186E5E-7C4D-4E2B-9C8A-DC1B88978B24Q33562184-1B8647B4-57D6-47BD-B7AF-950324326B98Q33881516-F14BC746-886A-4D50-9C55-A9B22F696245Q34139490-7B2E9518-788D-4C10-B7FF-A2ECF5E72C7BQ34637901-BA4AF163-6A4B-4F9C-8A41-FAD2927C183CQ34660924-99041187-9B9C-4051-ACE5-274700C2B70AQ34777137-E868BF13-54FB-45AC-B2AC-742D853D8EAEQ34788832-895B68E5-6150-4BBE-B5A1-F851909C3D2EQ34858558-768D04C3-E063-44C5-BF70-3897825BE0C0Q35815986-5E535445-F2BC-41DE-8378-B3D400CD6A20Q35848889-16093AD5-09C5-4BEF-BE69-DB366A418B02Q35852118-333409D0-7A44-4493-A64E-344EC8428E58Q36049489-706BD7AB-BF62-4082-A630-5AD0F914F961Q36378302-29618F11-C6FA-4333-BB01-49574C963093Q36675623-A9DA3409-2CC5-4E26-9468-D62F31CA6845Q36787432-C45FEAB8-3C3D-4D68-89B1-DCA63B77824EQ36796209-586B1CD5-B71E-45D7-8BBE-46D5C00852F2Q37064755-6DC42FDF-7577-4B72-998C-4FF23887C4AFQ37496682-2310D90E-C43F-4C3A-96E6-8DC5DF6515B9Q37563414-D3216CB7-7DBE-49FB-96AE-6F311D7A30B5Q38087650-70F35D9B-7E8E-45C3-9E03-8D17F1303735Q38125525-5F5EDFE0-43AF-487B-ACC4-B1334CF751C8Q38154740-4FA07DAE-A645-42DC-B192-90D6D57380BEQ38240756-BE9E2C15-A362-4357-B877-48E4C7EB413BQ38362661-981EC0D4-871E-453F-B81C-C59DA2507590Q38550921-7283C98A-E3E6-4ABD-9E60-AC2A736FFCDFQ38947467-7BD858B3-F852-4725-8B94-EFB980328CC2Q39395345-993F8E84-35A5-450A-8F29-D3C4FF166DD2Q39402899-2E64D6BB-2FE2-48F7-A2CC-DD06F50CB11BQ39637172-2BB5B1BE-E49F-412B-89E1-2D023235EFCFQ40661319-C5B57DC0-69B5-47EE-AF86-92B453B7F2BFQ41287485-A636C3EB-DBDB-48F2-992E-E83540A3DFD4Q41681579-A3CA5CA8-A5E1-42B1-B471-EB0D5055BEDDQ42756543-27A5E427-7D3C-4D6C-9873-37183E67FFF0Q47222005-8AC7B687-6F46-4606-A463-84D5A9862119
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Biochemical basis of asthma therapy.
@ast
Biochemical basis of asthma therapy.
@en
type
label
Biochemical basis of asthma therapy.
@ast
Biochemical basis of asthma therapy.
@en
prefLabel
Biochemical basis of asthma therapy.
@ast
Biochemical basis of asthma therapy.
@en
P2860
P356
P1476
Biochemical basis of asthma therapy.
@en
P2093
Peter J Barnes
P2860
P304
32899-32905
P356
10.1074/JBC.R110.206466
P407
P577
2011-07-28T00:00:00Z